NCT03985436 is a NA clinical trial of Trek for Surgical Success in Lumbar; Injury, sponsored by Sara Davin, PsyD, MPH.

Who is sponsoring NCT03985436?

NCT03985436 is sponsored by Sara Davin, PsyD, MPH.

What drugs are being tested in NCT03985436?

Interventions in NCT03985436: Trek for Surgical Success.

What condition does NCT03985436 study?

NCT03985436 studies Lumbar; Injury.

Is NCT03985436 still recruiting?

NCT03985436 is currently completed. Last updated 17 November 2020.

Last reviewed 2020-11-17 · How we verify

NCT03985436

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Single Session Pain Psychology Class for Spine Surgery Patients

Completed NA Last updated 17 November 2020

What this trial tests

NA trial testing Trek for Surgical Success in Lumbar; Injury in 20 participants. Completed in 1 November 2020.

Timeline

10 June 2019

Primary endpoint
1 November 2020

1 November 2020

Quick facts

Lead sponsor	Sara Davin, PsyD, MPH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	20
Start date	10 June 2019
Primary completion	1 November 2020
Estimated completion	1 November 2020
Sites	1 location across United States

Drugs / interventions tested

Trek for Surgical Success

Conditions studied

Lumbar; Injury — all drugs for Lumbar; Injury →

Sponsor

Sara Davin, PsyD, MPH

Who can join

18 and older, any sex, with Lumbar; Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project tests the feasibility a single session pain psychology class (TREK for Surgical Success) for patients undergoing spine surgery and compares outcomes in those who engage in the class to a historical group of similar patients undergoing usual care perioperatively. As of January 2020, the class option has been updated to include an online video module platform, to be used for patients unable to attend in person.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03985436 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sara Davin, PsyD, MPH
Last refreshed: 17 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03985436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing